Dr. Aradhna Agarwal
Rheumatology (Rheumatology Physician)
At a glance
- Medical school
- Ohio State University College of Medicine (2020)
- Years since graduation
- 6
- In the NPI registry since
- 2020
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2020Medical school: Ohio State University College of Medicine
- 2020Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
NY license 322693 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
Medical groups
- Trustees of Columbia University in The City of New York (2,296 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in New York, NY | 53 |
| Hydroxychloroquine Sulfate Other prescribers in New York, NY | 51 |
| Prednisone Other prescribers in New York, NY | 34 |
| Mycophenolate Mofetil Other prescribers in New York, NY | 29 |
| Folic Acid Other prescribers in New York, NY | 24 |
| Humira(Cf) Pen (adalimumab) Other prescribers in New York, NY | 17 |
| Diclofenac Sodium Other prescribers in New York, NY | 14 |
| Benlysta (belimumab) | 13 |
| Duloxetine Hcl Other prescribers in New York, NY | 12 |
| Otrexup (methotrexate/pf) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $1,330 in total to this clinician.
| AstraZeneca UK Limited | $1,043 |
|---|---|
| AbbVie Inc. | $150 |
| Aurinia Pharma U.S., Inc. | $137 |
| Travel and Lodging | $755 |
|---|---|
| Food and Beverage | $575 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Oct 10, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Houston, TX · in-kind Company’s descriptionSpeaker Expenses | $604 |
| AstraZeneca UK Limited Oct 10, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Houston, TX · in-kind Company’s descriptionSpeaker Expenses | $151 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.